Reuters logo
BRIEF-Erytech Pharma ‍to present pre-clinical data for metabolical disorders medicine
September 1, 2017 / 9:34 AM / 3 months ago

BRIEF-Erytech Pharma ‍to present pre-clinical data for metabolical disorders medicine

Sept 1 (Reuters) - ERYTECH PHARMA SA:

* ‍TO PRESENT PRE-CLINICAL DATA AT 13TH INTERNATIONAL CONGRESS OF INBORN ERRORS OF METABOLISM​

* ‍ERYMINASE, WHICH IS ARGININE DEIMINASE ENCAPSULATED IN RED BLOOD CELLS, WAS SHOWN TO REDUCE ARGININE LEVELS IN A DISEASE MODEL OF ARGINASE-1 DEFICIENCY​

* ERYMETHIONASE, METHIONINE-Γ-LYASE ENCAPSULATED IN RED BLOOD CELLS, WAS SHOWN TO LOWER HOMOCYSTEINE LEVELS, SUPPORTING A POTENTIAL TREATMENT APPROACH FOR HOMOCYSTINURIA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below